Chimeric anti CD44 antibodies and their use for treating acute myeloid leukemia

Details for Australian Patent Application No. 2004290918 (hide)

Owner University Health Network Institut Na- tional de la Sante et de la Recherche Medicale

Inventors Boumsell, Laurence; Dick, John E.; Kadouche, Jean; Smadja, Florence

Agent Watermark

Pub. Number AU-B-2004290918

PCT Pub. Number WO2005/049082

Priority 03292873.1 19.11.03 EP

Filing date 19 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 8 March 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049082 Priority application(s): WO2005/049082

22 May 2008 Amendment Made

  The nature of the amendment is: Add Co-Inventor: Boumsell, Laurence

8 March 2012 Application Accepted

  Published as AU-B-2004290918

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290925-Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients

2004290907-Support element